Cas 894257-94-4,N-(4-chlorophenyl)-2-(2-(2,6-dichlorophenyl)acetyl)hydrazinecarbothioamide

894257-94-4

Post Buying Request

Basic information

Product Name: N-(4-chlorophenyl)-2-(2-(2,6-dichlorophenyl)acetyl)hydrazinecarbothioamide
Synonyms: N-(4-chlorophenyl)-2-(2-(2,6-dichlorophenyl)acetyl)hydrazinecarbothioamide
CAS NO:894257-94-4
Molecular Formula:
Molecular Weight: 388.705
EINECS: N/A
Product Categories: N/A
Mol File: 894257-94-4.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-(4-chlorophenyl)-2-(2-(2,6-dichlorophenyl)acetyl)hydrazinecarbothioamide(CAS DataBase Reference)
NIST Chemistry Reference: N-(4-chlorophenyl)-2-(2-(2,6-dichlorophenyl)acetyl)hydrazinecarbothioamide(894257-94-4)
EPA Substance Registry System: N-(4-chlorophenyl)-2-(2-(2,6-dichlorophenyl)acetyl)hydrazinecarbothioamide(894257-94-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 894257-94-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

894257-94-4 Suppliers

Recommended suppliersmore

894257-94-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 894257-94-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,4,2,5 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 894257-94:
(8*8)+(7*9)+(6*4)+(5*2)+(4*5)+(3*7)+(2*9)+(1*4)=224
224 % 10 = 4
So 894257-94-4 is a valid CAS Registry Number.

894257-94-4Upstream product

894257-94-4Downstream Products

1045820-01-6 JLJ₀₂₂₄

894257-94-4Relevant articles and documents

NOVEL AZOLES AND RELATED DERIVATIVES AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIS) IN ANTIVIRAL THERAPY (HIV)

-

Page/Page column 30-31, (2009/03/07)

The present invention relates to novel heterocyclic compounds, including oxadiazole compounds, pharmaceutical compositions and their use in the inhibition of reverse transcriptase and the treatment of HIV (1 and 2) infections, AIDS and ARC and other viral

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 894257-94-4